TrialPloS one2015

First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study.

Niels Andreasen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.